| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6670335 | VALEANT PHARMS NORTH | Fluorouracil-containing formulation |
Jun, 2021
(2 years ago) | |
Carac is owned by Valeant Pharms North.
Carac contains Fluorouracil.
Carac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Carac are:
- US6670335
Carac was authorised for market use on 27 October, 2000.
Carac is available in cream;topical dosage forms.
Carac can be used as treatment of actinic keratosis.
The generics of Carac are possible to be released after 02 June, 2021.
Drugs and Companies using FLUOROURACIL ingredient
Market Authorisation Date: 27 October, 2000
Treatment: Treatment of actinic keratosis
Dosage: CREAM;TOPICAL
How can I launch a generic of CARAC before it's drug patent expiration?
More Information on Dosage
CARAC family patents
